– Dorzagliatin, also known as HMS 5552, RO5305552 and sinogliatin, is a novel Dual-Acting Glucokinase Activator, which Improves Glycaemic Control and Pancreatic ?-Cell Function in Patients With Type 2 Diabetes. By addressing the defect of the glucose sensor